Healthcare provider profile · identity verified

Andrew Yim

Nurse Practitioner · NEW HAVEN, CT · NPI 1902874530

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	397	87
Albuterol Sulfate Hfa	Albuterol Sulfate	268	50
Amlodipine Besylate	Amlodipine Besylate	242	72
Lisinopril	Lisinopril	209	58
Gabapentin	Gabapentin	179	47
Pantoprazole Sodium	Pantoprazole Sodium	165	42
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	161	23
Meloxicam	Meloxicam	145	30
Metformin Hcl	Metformin Hcl	141	32
Ibuprofen	Ibuprofen	140	35
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	138	14
Rosuvastatin Calcium	Rosuvastatin Calcium	119	36
Metformin Hcl Er	Metformin Hcl	118	29
Losartan Potassium	Losartan Potassium	99	28
Ozempic	Semaglutide	98	18
Pregabalin	Pregabalin	98	15
Montelukast Sodium	Montelukast Sodium	95	19
Levothyroxine Sodium	Levothyroxine Sodium	90	25
Famotidine	Famotidine	87	24
Pravastatin Sodium	Pravastatin Sodium	86	20
Fluticasone Propionate	Fluticasone Propionate	84	35
Metoprolol Succinate	Metoprolol Succinate	84	21
Tramadol Hcl	Tramadol Hcl	84	11
Trazodone Hcl	Trazodone Hcl	81	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	78	23
Ventolin Hfa	Albuterol Sulfate	77	21
Alprazolam	Alprazolam	76	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	73	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	70	22
Baclofen	Baclofen	59	14
Buprenorphine Hcl	Buprenorphine Hcl	59	suppressed
Trulicity	Dulaglutide	59	suppressed
Breo Ellipta	Fluticasone/Vilanterol	55	12
Lidocaine	Lidocaine	55	18
Mirtazapine	Mirtazapine	55	19
Oxycodone Hcl	Oxycodone Hcl	55	suppressed
Furosemide	Furosemide	53	17
Tamsulosin Hcl	Tamsulosin Hcl	51	17
Farxiga	Dapagliflozin Propanediol	50	16
Hydroxyzine Hcl	Hydroxyzine Hcl	48	14
Omeprazole	Omeprazole	47	18
Jardiance	Empagliflozin	46	14
Diclofenac Sodium	Diclofenac Sodium	44	21
Januvia	Sitagliptin Phosphate	43	suppressed
Mounjaro	Tirzepatide	42	suppressed
Potassium Chloride	Potassium Chloride	40	suppressed
Chlorthalidone	Chlorthalidone	39	14
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	39	suppressed
Simvastatin	Simvastatin	39	suppressed
Duloxetine Hcl	Duloxetine Hcl	37	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	36	11
Spironolactone	Spironolactone	36	11
Tizanidine Hcl	Tizanidine Hcl	36	suppressed
Naproxen	Naproxen	35	11
Varenicline Tartrate	Varenicline Tartrate	35	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	34	11
Clopidogrel	Clopidogrel Bisulfate	32	12
Clonidine Hcl	Clonidine Hcl	31	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	31	15
Sertraline Hcl	Sertraline Hcl	31	11
Valacyclovir	Valacyclovir Hcl	31	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	29	suppressed
Humalog Kwikpen U-100	Insulin Lispro	29	13
Pioglitazone Hcl	Pioglitazone Hcl	28	suppressed
Symbicort	Budesonide/Formoterol Fumarate	28	suppressed
Alendronate Sodium	Alendronate Sodium	27	suppressed
Carvedilol	Carvedilol	27	suppressed
Clonazepam	Clonazepam	27	suppressed
Enalapril Maleate	Enalapril Maleate	27	suppressed
Rizatriptan	Rizatriptan Benzoate	26	suppressed
Entresto	Sacubitril/Valsartan	25	suppressed
Prednisone	Prednisone	25	17
Meclizine Hcl	Meclizine Hcl	24	suppressed
Glipizide Er	Glipizide	23	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	23	suppressed
Eliquis	Apixaban	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Glimepiride	Glimepiride	22	suppressed
Ketoconazole	Ketoconazole	22	suppressed
Ramipril	Ramipril	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	12
Hydrocortisone	Hydrocortisone	21	13
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	21	suppressed
Nystatin	Nystatin	20	suppressed
Ubrelvy	Ubrogepant	20	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	19	suppressed
Indapamide	Indapamide	18	suppressed
Linzess	Linaclotide	18	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Suboxone	Buprenorphine Hcl/Naloxone Hcl	18	suppressed
Torsemide	Torsemide	17	suppressed
Tretinoin	Tretinoin	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	11
Bupropion Xl	Bupropion Hcl	16	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	16	suppressed
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Zubsolv	Buprenorphine Hcl/Naloxone Hcl	16	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Mexiletine Hcl	Mexiletine Hcl	15	suppressed
Morphine Sulfate Er	Morphine Sulfate	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	14	suppressed
Ammonium Lactate	Ammonium Lactate	14	suppressed
Econazole Nitrate	Econazole Nitrate	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Glipizide	Glipizide	13	suppressed
Levemir Flexpen	Insulin Detemir	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Unifine Pentips	Pen Needle, Diabetic	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Risperidone	Risperidone	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Allopurinol	Allopurinol	11	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Novolin R	Insulin Regular, Human	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Temazepam	Temazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error